| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |